Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.
David EasterhoffM Anthony MoodyDaniela FeraHao D ChengMargaret AckermanKevin WieheKevin O SaundersJustin PollaraNathan VandergriftRob ParksJerome H KimNelson L MichaelRobert J O'ConnellJean-Louis ExclerMerlin L RobbSandhya VasanSupachai Rerks-NgarmJaranit KaewkungwalPunnee PitisuttithumSorachai NitayaphanFaruk SinangilJames TartagliaSanjay PhogatThomas B KeplerS Munir AlamHua-Xin LiaoGuido FerrariMichael S SeamanDavid C MontefioriGeorgia D TomarasStephen C HarrisonBarton F HaynesPublished in: PLoS pathogens (2017)
ClinicalTrials.gov NCT01435135.